Pharma Archives - Life Sciences Times

Portal Innovations Expands to South Boston

March 30, 2023

Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer

March 29, 2023

Labviva Secures $20M in Series A Financing to Transform the Life Sciences Procurement Industry Using AI

March 27, 2023

Colliers Advises Vibalogics in 118,000-SF Life Science Deal in Boxborough

November 13, 2020

New England Biolabs Leases 28,000 SF

December 7, 2020

Boston Properties Announces 138,000 Square Foot, 10-Year Lease With Translate Bio in Waltham, Massachusetts

November 10, 2020

ABOUT US

Life Science Times is New England’s premier life sciences publication, covering the Pharma, Biotech, MedTech and Public Health sectors nationwide with a special focus on New England. Updated daily, we cover the latest news in everything else that touches any rubric of the rapidly growing life sciences industry.

Pharma

AmbioPharm To Utilize YMC Twin-Column Chromatography in Large Scale Peptide Production

Alzamend Neuro Announces Completion of Clinical Portion of Phase IIA Multiple Ascending Dose Clinical Trial for AL001 Treatment of Dementia Related to Alzheimer’s

Kite’s Yescarta® CAR T-cell Therapy Demonstrates a Statistically Significant Improvement in Overall Survival for Initial Treatment of Relapsed/Refractory Large B-cell Lymphoma

Akston Biosciences Ends Vaccine Partnership with Stelis, Continues to Advance COVID Universal Booster EUA

The Access to Advanced Health Institute Reports Encouraging Results of First-In-Human Trial of Its Temperature-Stable Tuberculosis Vaccine Candidate

Most Read

Children’s Hospital Los Angeles Appoints Lara Khouri as Chief Operating Officer

BeiGene Appoints Julius Pryor III as First Global Head of Diversity and Health Equity

Stryker Now Offers the Only FDA-Cleared Pyrocarbon Bearing Material Option for Shoulder Hemiarthroplasty

Portal Innovations Expands to South Boston

EDITOR PICKS

Portal Innovations Expands to South Boston

Lucy Therapeutics Appoints Neuroscience Drug Discovery and Development Expert Christopher J. Winrow, Ph.D., as Chief Scientific Officer

Labviva Secures $20M in Series A Financing to Transform the Life Sciences Procurement Industry Using AI

POPULAR POSTS

Colliers Advises Vibalogics in 118,000-SF Life Science Deal in Boxborough

New England Biolabs Leases 28,000 SF

Boston Properties Announces 138,000 Square Foot, 10-Year Lease With Translate Bio in Waltham, Massachusetts

POPULAR CATEGORY

ABOUT US

FOLLOW US